Oramed Pharmaceuticals, Inc. (ORMP)
3.39
+0.07
(+2.11%)
USD |
NASDAQ |
Jan 23, 16:00
3.40
+0.01
(+0.29%)
After-Hours: 20:00
Oramed Pharmaceuticals Research and Development Expense (TTM): 5.854M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Lifeward Ltd. | 3.537M |
| Bristol Myers Squibb Co. | 9.719B |
| Nektar Therapeutics | 116.36M |
| Innoviva, Inc. | 29.71M |
| Theravance Biopharma, Inc. | 37.97M |